Additional file 1: of Randomized, open-label, comparative phase IV study on the bioavailability of Ciclosporin Pro (Teva) versus SandimmunŽ Optoral (Novartis) under fasting versus fed conditions in patients with stable renal transplants GäcklerAnja DolffSebastian RohnHana KorthJohannes WildeBenjamin EisenbergerUte MitchellAnna KribbenAndreas WitzkeOliver 2019 Figure S1. Inclusion and exclusion criteria. (DOCX 27 kb)